Smoking News and Research

RSS

Smartphone overdependence may signal higher alcohol and smoking risk in teens

Higher smartphone overdependence was significantly associated with greater odds of self-reported lifetime alcohol and tobacco use among more than 100,000 Korean adolescents. The study found graded dose-response patterns, with earlier initiation and heavier alcohol or smoking behaviors linked to a higher adjusted probability of high-risk smartphone overdependence.

21 May 2026

Researchers discover unexpected cellular triggers for precancerous pancreas lesions

In an unexpected finding, a new study flips on its head researchers' understanding of how precancerous pancreas lesions evolve into pancreatic cancer.

21 May 2026

Targeting tumor-specific inflammatory process may prevent drug resistance in colon cancer

Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse.

21 May 2026

GLP-1 drugs may help curb addiction by targeting reward pathways

GLP-1 receptor agonists, already used for Type 2 diabetes and obesity, show promise in reducing alcohol and drug-seeking behaviors through central reward and dopamine-related pathways. Most evidence remains preclinical, with limited early human data, so larger clinical trials are needed before these drugs can be recommended for addiction treatment.

21 May 2026

Smoking cessation may reduce dementia risk for people who avoid major weight gain

Quitting smoking may be associated with a lowered risk of dementia, especially for people who avoid major weight gain after quitting, according to a study published May 20, 2026, in Neurology, the medical journal of the American Academy of Neurology.

20 May 2026

Women may face greater cognitive impact from dementia risk factors

Researchers from the University of California San Diego School of Medicine found that women not only experience a higher burden of certain modifiable dementia risk factors, but also appear more vulnerable to their effects on cognitive function.

20 May 2026

Ensitrelvir cuts household COVID-19 risk when given after exposure

Ensitrelvir, an oral SARS-CoV-2 3C-like protease inhibitor, reduced symptomatic RT-PCR-confirmed COVID-19 among household contacts when given within 72 hours after symptom onset in the infected index patient. In the phase 3 SCORPIO-PEP trial, COVID-19 occurred in 2.9% of ensitrelvir recipients versus 9.0% of placebo recipients, with similar overall adverse-event rates.

20 May 2026

560-610 minutes of exercise a week linked to substantial cardiovascular health benefits

Adults should aim to do between 560 and 610 minutes a week of moderate to vigorous physical activity to achieve a substantial reduction in the risk of heart attacks and stroke, suggest the findings of an observational study published online in the British Journal of Sports Medicine.

19 May 2026

Why AI tools need clearer guardrails in high-stakes health research

AI-enabled research tools can accelerate health research, but their data-science roots may clash with epidemiological workflows built around prespecified designs, causal reasoning, bias control, and reproducibility. The article argues that researchers should integrate AI cautiously, using clear workflow boundaries, peer review of AI outputs, and sustained human accountability.

19 May 2026

New guidelines urge earlier cholesterol treatment to prevent heart disease

Doctors should consider treating high cholesterol much earlier and more aggressively than they have in the past, according to a new perspective by Weill Cornell Medicine, NewYork-Presbyterian and Yale School of Medicine investigators.

19 May 2026

Real-world study compares leading ALK+ lung cancer treatments

A team of researchers from the Keck School of Medicine of USC, the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences and the USC Shaeffer Center for Health Policy & Economics have conducted a head-to-head comparison of five leading treatments for anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer.

19 May 2026

Sensory nerve signals found to block lung cancer immunotherapy

Researchers at the Francis Crick Institute have revealed that sensory nerve signals interfere with the immune system's response to lung cancer.

19 May 2026

Switching to pod-based e-cigarette could improve the odds of quitting smoking

Cigarette smoking is the leading preventable cause of death in the United States, even as rates of cigarette smoking have fallen to an all-time low of approximately 10% in 2024.

19 May 2026

New report highlights widening cardiovascular health inequalities across Europe

Cardiovascular disease (CVD) remains one of Europe's biggest health challenges, according to new data from the European Society of Cardiology (ESC) Atlas of Cardiology, published in the European Heart Journal.

19 May 2026

Study measures smoking-related mechanical changes in human lungs

For the first time, scientists have directly measured how smoking changes the mechanical behavior of human lung tissue.

19 May 2026

Blood metabolite patterns could reveal dementia risk in midlife

Research shows that blood metabolite profiles can indicate dementia risk, offering a potential tool for early detection and prevention of cognitive decline.

18 May 2026

Olive waste extract may help lower fat and improve muscle markers

A polyphenol-rich olive oil byproduct may enhance muscle health, reducing fat mass and improving antioxidant markers in adults with metabolic risk factors.

18 May 2026

Maternal occupations linked to increased autism diagnosis odds

Findings indicate that certain maternal jobs are associated with increased autism odds in children, highlighting the importance of prenatal occupational health.

15 May 2026

Perimenopause nearly doubles women’s odds of poor heart health

Perimenopause is linked to worsening cardiovascular health, with significant declines in lipid and glucose scores, emphasizing the need for early assessment.

15 May 2026

Research identifies significant spike in neurological disorders during the covid-19 pandemic

In 2021, neurological diseases affected 3.40 billion individuals worldwide, corresponding to 43.1 % of the global population. In China, rapid demographic shifts and lifestyle changes have contributed to a continued rise in the burden of stroke, dementia, and Parkinson's disease-a trend expected to persist.

15 May 2026